<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25799554</article-id><article-id pub-id-type="pmc">4370456</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0120418</article-id><article-id pub-id-type="publisher-id">PONE-D-14-43302</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Epidermal Growth Factor-Mediated Mitogen-Activated Protein Kinase3/1 Pathway Is Conducive to <italic>In Vitro</italic> Maturation of Sheep Oocytes</article-title><alt-title alt-title-type="running-head">MAPK3/1 Pathway Is Conducive to Sheep Oocytes Maturation In Vitro</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Ni</surname><given-names>Hemin</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sheng</surname><given-names>Xihui</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Cui</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Meichao</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yunhai</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Xiaolong</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Xing</surname><given-names>Shuhan</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Yong</given-names></name><xref rid="cor001" ref-type="corresp">*</xref><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001">
<addr-line>Animal Science and Technology College, Beijing University of Agriculture, Beijing, China</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Zhang</surname><given-names>Meijia</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>China Agricultural University, CHINA</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: YG HMN. Performed the experiments: XHS XC. Analyzed the data: HMN XHS XC MCG YHL. Contributed reagents/materials/analysis tools: YHL XLQ SHX. Wrote the paper: XHS YG XC.</p></fn><corresp id="cor001">* E-mail: <email>y63guo@126.com</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>3</issue><elocation-id>e0120418</elocation-id><history><date date-type="received"><day>25</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Ni et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Ni et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0120418.pdf"/><abstract><p>Epidermal growth factor (EGF) has been shown to facilitate the <italic>in vitro</italic> maturation of sheep oocytes, and enhance embryo&#x02019;s capability for further development. However, such kind of molecular mechanism has not yet been elucidated. In the present study, we investigated the effect of EGF-mediated mitogen-activated protein kinases 3 and 1 (MAPK3/1) pathway on <italic>in vitro</italic> maturation of sheep oocytes. U0126, a specific inhibitor of MEK (MAPK kinase), was added into the maturation culture medium to block the EGF-mediated MAPK3/1 pathway with different doses. Then, the nuclear maturation of sheep oocytes was examined. Additionally, the effect of EGF-mediated MAPK3/1 on cytoplasmic maturation was examined though <italic>in vitro</italic> fertilization and embryonic development. The rate of germinal vesicle breakdown (GVBD) after 6 h of culture with 10<sup>&#x02212;4</sup> mol/l of U0126 (50.4%) was significantly decreased compared with control (67.2%, <italic>p</italic> &#x0003c; 0.05), and the first polation body (PB1) extrusion rate after 22 h of culture in drug treatment was also significantly inhibited compared with control (28.6% vs. 48.4%, p &#x0003c; 0.05). However, 10<sup>&#x02212;6</sup> mol/l U0126 had slight effect on oocyte nuclear maturation. The normal distribution rate of &#x003b1;-tubulin in the oocytes after 22 h of <italic>in vitro</italic> maturation was significantly decreased in the 10<sup>&#x02212;4</sup> mol/l U0126 group (54%) compared with control (68%, <italic>p</italic> &#x0003c; 0.05). After <italic>in vitro</italic> fertilization, the cleavage rate in drug treatments (56.8% in 10<sup>&#x02212;6</sup> mol/l U0126 group and 42.6% in 10<sup>&#x02212;4</sup> mol/l U0126 group) was significantly decreased compared with control (72.3%, <italic>p</italic> &#x0003c; 0.01). The blastocyst rate in 10<sup>&#x02212;4</sup> mol/l U0126 group (17.6%) was also significantly decreased compared with control (29.9%, <italic>p</italic> &#x0003c; 0.05). Collectively, these results suggest that EGF-mediated MAPK3/1 pathway is conducive to <italic>in vitro</italic> maturation of sheep oocytes.</p></abstract><funding-group><funding-statement>This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31272526, Grant No.31402049), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (Grant No. PXM2013_014207_000067), and the science and technology project of Beijing Municipal Commission of Education (Grant No. PXM 2014_014207_000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="5"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>In mammals, luteinizing hormone (LH) from the pituitary induces a sequential and transient expression of the epidermal growth factor (EGF)-like growth factors such as epiregulin, amphiregulin, and betacellulin expressed in mural granulosa cells (MGCs) [<xref rid="pone.0120418.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0120418.ref002" ref-type="bibr">2</xref>]. These growth factors then activate common EGF receptor (EGFR) in cumulus cells to stimulate oocyte maturation [<xref rid="pone.0120418.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0120418.ref003" ref-type="bibr">3</xref>]. Recently, it has been reported that EGF-like growth factors could also regulate maternal mRNA translation and developmental competence of mouse oocytes by activation of the PI(3)K-AKT-mTOR pathway [<xref rid="pone.0120418.ref004" ref-type="bibr">4</xref>].</p><p>The oocyte is maintained in meiotic prophase arrest by natriuretic peptide type C (NPPC) acting via its cognate receptor, natriuretic peptide receptor 2 (NPR2) [<xref rid="pone.0120418.ref005" ref-type="bibr">5</xref>]. Some evidences show that EGFR signaling induces meiotic resumption by downregulating <italic>Nppc</italic> mRNA expression [<xref rid="pone.0120418.ref006" ref-type="bibr">6</xref>], and decreases NPR2 guanylyl cyclase activity via the elevation of calcium concentrations of cumulus cells [<xref rid="pone.0120418.ref007" ref-type="bibr">7</xref>]. Both of which lead to the decrease of cGMP levels in the follicle [<xref rid="pone.0120418.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0120418.ref010" ref-type="bibr">10</xref>]. Anyway, the key downstream effectors of EGFR signaling in cumulus cells, mitogen-activated protein kinases 3 and 1 (MAPK3/1, also known as ERK1/2), is essential for mammalian oocyte maturation [<xref rid="pone.0120418.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0120418.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0120418.ref011" ref-type="bibr">11</xref>]. It has been demonstrated that, in mouse and pig oocytes, MAPK3/1 pathway is essential for spindle assembly and microtubule organization during mammalian oocyte meiosis [<xref rid="pone.0120418.ref012" ref-type="bibr">12</xref>, <xref rid="pone.0120418.ref013" ref-type="bibr">13</xref>]. In bovine oocytes, it is responsible for MII arrest, maintenance of maturation-promoting factor (MPF) activity, and spindle organization [<xref rid="pone.0120418.ref014" ref-type="bibr">14</xref>].</p><p>The maturation of mammalian oocytes is a complex and dynamic process involving the maturation of nucleus and cytoplasm [<xref rid="pone.0120418.ref015" ref-type="bibr">15</xref>]. Only oocytes with a mature nucleus and cytoplasm are able to support normal fertilization and further embryonic development [<xref rid="pone.0120418.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0120418.ref017" ref-type="bibr">17</xref>]. At present, the acquirement of large livestock&#x02019;s mature oocytes is difficult, so it is necessary to obtain massive <italic>in vitro</italic> matured oocytes with high quality, in spite that the developmental competence of oocytes matured <italic>in vitro</italic> is markedly inferior to that of their <italic>in vivo</italic> matured counterparts [<xref rid="pone.0120418.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pone.0120418.ref020" ref-type="bibr">20</xref>].</p><p>Many studies show that the activation of EGFR by the addition of EGF <italic>in vitro</italic> can facilitate the maturation of sheep oocytes, and enhance the embryo&#x02019;s capability for further development [<xref rid="pone.0120418.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pone.0120418.ref023" ref-type="bibr">23</xref>]. However, the mechanism is unclear. This study was aimed to investigate the effect of EGF-mediated MAPK3/1 pathway on <italic>in vitro</italic> maturation of sheep oocytes. U0126, a specific inhibitor of MEK (MAPK kinase), was added to the maturation culture medium to block the EGF-mediated downstream MAPK3/1 pathway. Then, the maturation of nucleus was examined. Additionally, the cytoplasmic maturation was examined through <italic>in vitro</italic> fertilization and embryonic development.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Ethics Statement</title><p>Animal welfare and experimental procedures were carried out in accordance with the Guide for the Care and Use of Laboratory Animals (Ministry of Science and Technology of China, 2006), and were approved by the animal ethics committee of Beijing University of Agriculture.</p></sec><sec id="sec004"><title>Oocyte collection and maturation culture</title><p>Sheep ovaries were collected from Fuhua slaughterhouse (Dachang Hui Autonomy County, Hebei province) and were immediately placed in 25&#x02013;28&#x000b0;C normal saline containing penicillin-streptomycin, then transported to the laboratory within 2&#x02013;4 h. The ovaries were washed three times in normal saline and trimmed to remove fat and the corpus luteum. Then, ovaries were placed in a petri dish containing oocyte pick-up solution (<xref rid="pone.0120418.t001" ref-type="table">Table 1</xref>) and removed the ovarian follicle. According to the test needs, cumulus-oocyte complexes were sorted out under a stereomicroscope (Olympus SZ40, Tokyo, Japan). The selection criteria were as follows: complete morphology, dense cytoplasm, uniform color, at least three layers of granular cells, and dense encapsulation.</p><table-wrap id="pone.0120418.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.t001</object-id><label>Table 1</label><caption><title>The recipes of reagents.</title></caption><alternatives><graphic id="pone.0120418.t001g" xlink:href="pone.0120418.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Reagent</th><th align="left" rowspan="1" colspan="1">Recipe</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Oocyte pick-up solution</td><td align="left" rowspan="1" colspan="1">TCM199 + 25 mmol/l HEPES + 2.2 mg/ml NaHCO<sub>3</sub> + 2% FCS + 100 IU/ml streptomycin + 100 &#x003bc;g/ml penicillin</td></tr><tr><td align="left" rowspan="1" colspan="1">Maturation culture medium I</td><td align="left" rowspan="1" colspan="1">TCM199 + 10 mmol/l HEPES + 2.2 mg/ml NaHCO<sub>3</sub> + 8 mg/ml BSA + 0.25 mmol/l sodium pyruvate + 2.75 mmol/l lactate + 100 IU/ml penicillin + 100 &#x003bc;g/ml streptomycin + 50 ng/ml EGF +1 &#x003bc;g/ml E<sub>2</sub> + 10 &#x003bc;g/ml LH + 10 &#x003bc;g/ml FSH</td></tr><tr><td align="left" rowspan="1" colspan="1">Maturation culture medium II</td><td align="left" rowspan="1" colspan="1">Maturation culture medium I with 10<sup>&#x02212;6</sup> mol/l U0126</td></tr><tr><td align="left" rowspan="1" colspan="1">Maturation culture medium III</td><td align="left" rowspan="1" colspan="1">Maturation culture medium I with 10<sup>&#x02212;4</sup> mol/l U0126</td></tr><tr><td align="left" rowspan="1" colspan="1">SOF working solution</td><td align="left" rowspan="1" colspan="1">SOF stock solution + 1 mmol/l glutamine + 0.3 mmol/l sodium pyruvate</td></tr><tr><td align="left" rowspan="1" colspan="1">Oocyte washing solution</td><td align="left" rowspan="1" colspan="1">SOF working solution + 10 mmol/l HEPES + 5 mmol/l NaHCO<sub>3</sub> + 0.3% BSA + 100 IU/ml penicillin + 100 &#x003bc;g/ml streptomycin</td></tr><tr><td align="left" rowspan="1" colspan="1">Sperm-washing solution</td><td align="left" rowspan="1" colspan="1">The same ingredients as oocyte washing solution, with a double amount of double antibody</td></tr><tr><td align="left" rowspan="1" colspan="1">Capacitation solution</td><td align="left" rowspan="1" colspan="1">SOF working solution + 20% estrous sheep serum + 10 mmol/l penicillamine + 10 mmol/l hypotaurine + 10 &#x003bc;g/ml heparin + 0.5 mol/l calcium lactate + 100 IU/ml penicillin + 100 &#x003bc;g/ml streptomycin</td></tr><tr><td align="left" rowspan="1" colspan="1">Embryo culture medium</td><td align="left" rowspan="1" colspan="1">SOF working solution + 10% FCS + 2% essential amino acids (BME-EAA) + 1% nonessential amino acids (MEM-NEAA) + 100 IU/ml penicillin + 100 &#x003bc;g/ml streptomycin</td></tr></tbody></table></alternatives></table-wrap><p>U0126 (Sigma-Aldrich, MO, USA) was added into the maturation culture medium with different concentrations (0, 10<sup>&#x02212;6</sup>, and 10<sup>&#x02212;4</sup> mol/l), and each group had three replicates. Then three groups of oocytes were respectively rinsed using different maturation culture medium by two times and transferred into 50 &#x003bc;l of pre-equilibrated maturation medium droplets (10 oocytes each). The incubation was performed at 38.5&#x000b0;C in an atmosphere of 5% CO<sub>2</sub> under saturated humidity.</p></sec><sec id="sec005"><title>Determination of oocyte nuclear maturation</title><sec id="sec006"><title>Examination of GVBD.</title><p>Examination of GVBD. After 6 h of <italic>in vitro</italic> maturation, different groups of oocytes were treated with the oocyte washing solution containing 0.1% hyaluronidase by mechanical pipetting to remove cumulus cells. The obtained oocytes were placed on a glass slide with droplets of paraffin wax: vaseline (1:9, v/v) in the four corners. Cells were covered with a coverslip and then fixed for more than 24 h in ethanol: acetic acid (3:1, v/v). Then, cells were stained with 1% aceto-orcein for 1&#x02013;2 min. GVBD were examined under a biological microscope (Nicon YS2, Tokyo, Japan).</p></sec><sec id="sec007"><title>Examination of PB1 extrusion.</title><p>After 24 h of <italic>in vitro</italic> maturation, different groups of oocytes were subjected to mechanical pipetting with the oocyte washing solution containing 0.1% hyaluronidase to remove cumulus cells. The extrusion of PB1 was examined under a stereomicroscope (Olympus SZ40, Tokyo, Japan) and taken as an indication of oocyte nuclear maturation for data analysis.</p></sec><sec id="sec008"><title>Immunofluorescence labeling of &#x003b1;-tubulin.</title><p>Different experimental groups of sheep oocytes were collected at varying maturity periods (4, 8, 12, and 24 h). The oocytes were digested in 0.5% hyaluronidase to completely remove granulosa cells, and the zona pellucida was removed with phosphate-buffered saline (PBS) (pH 2.5). The digested oocytes were fixed in 4% paraformaldehyde at room temperature for 20 min and then placed in 0.2% Triton-X100 (Sigma-Aldrich, MO, USA) for 30 min of osmosis. Thereafter, oocytes were incubated in a blocking agent (PBS +2% BSA + 10% goat serum + 2% skim milk powder + 0.15 mol/l glycine) at 37&#x000b0;C for 1 h, followed by the addition of FITC-conjugated mouse anti-human &#x003b1;-tubulin monoclonal antibody (ab64503) (Abcam DM1A, Cambridge, UK) with a final concentration of 1 &#x003bc;g/ml [<xref rid="pone.0120418.ref024" ref-type="bibr">24</xref>] and incubation at 37&#x000b0;C for another 1 h. The immunogen of antibody is full length native protein (purified) of Chicken alpha Tubulin (extracted from brain). At the end of incubation, oocytes were thoroughly washed in 0.2% Triton-X100, 5 &#x003bc;g/ml propidium iodide (Sigma-Aldrich, MO, USA) was added, and then they were placed in a cassette for 10 min of nuclide labeling. Finally, oocytes were examined under a confocal microscope (ZEISS LSM 510 META, Oberkochen, Germany).</p></sec></sec><sec id="sec009"><title>
<italic>In vitro</italic> fertilization of oocytes and embryo culture</title><sec id="sec010"><title>Sperm capacitation.</title><p>Fresh semen was washed twice with sperm-washing solution by centrifugation at 1500 rpm/min for 5 min. The supernatant was decanted and sperm at the bottom of the centrifuge tube was added to the pre-equilibrated capacitation solution for 30 min at 38.5&#x000b0;C in an atmosphere of 5% CO<sub>2</sub> under saturated humidity.</p></sec><sec id="sec011"><title>
<italic>In vitro</italic> fertilization.</title><p>Mature oocytes were digested with 0.5% hyaluronidase to partially remove granulosa cells. The oocytes were then washed thrice with the capacitation solution and transferred into fertilization droplets. Sperm was added to the fertilization droplet containing oocytes. Each drop contained 10 &#x003bc;l of sperm with a density of 5 &#x000d7; 10<sup>6</sup> sperm/ml. The oocyte-sperm complex was incubated for 17&#x02013;19 h at 38.5&#x000b0;C in a 5% CO<sub>2</sub> atmosphere under saturated humidity.</p></sec><sec id="sec012"><title>Embryo culture.</title><p>After 17&#x02013;19 h of oocyte-sperm co-incubation, zygotes were washed thrice with the oocyte washing solution to remove granulosa cells and sperm. After twice washes with the embryo culture medium, zygotes were transferred into droplet containing monolayer granulosa cell and incubated at 38.5&#x000b0;C in a 5% CO<sub>2</sub> atmosphere under saturated humidity. Half the medium was exchanged with new medium every other day. The cleavage rate was determined at 48 h and the blastocyst rate was estimated at 7d.</p></sec></sec><sec id="sec013"><title>Data analysis</title><p>All experiments were performed at least 3 times. The data were subjected to chi-square analysis using SAS 9.0 statistical software (SAS Institute Inc., Cary, NC, USA). A <italic>p-</italic>value less than 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec014"><title>Results</title><sec id="sec015"><title>Oocyte nuclear maturation in different treatment groups</title><p>The GVBD rate of sheep oocytes was examined after 6 h of <italic>in vitro</italic> maturation. After 6 h of <italic>in vitro</italic> maturation, the GVBD rate of mature sheep oocytes in the 10<sup>&#x02212;4</sup> mol/l U0126 group (50.4%) was significantly decreased compared with control (67.2%, <italic>p</italic> &#x0003c; 0.05). There was no significant differenceS between the 10<sup>&#x02212;6</sup> mol/l U0126 group and the control group (55.2% vs 67.2%, <italic>p &#x0003e;</italic> 0.05) (<xref rid="pone.0120418.t002" ref-type="table">Table 2</xref>).</p><table-wrap id="pone.0120418.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.t002</object-id><label>Table 2</label><caption><title>Statistics of germinal vesicle breakdown (GVBD) rate of sheep oocytes in different treatment groups after 6 h of <italic>in vitro</italic> maturation.</title></caption><alternatives><graphic id="pone.0120418.t002g" xlink:href="pone.0120418.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Total number of oocytes</th><th align="left" rowspan="1" colspan="1">Number of GVBD oocytes</th><th align="left" rowspan="1" colspan="1">GVBD rate (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="left" rowspan="1" colspan="1">113</td><td align="left" rowspan="1" colspan="1">76</td><td align="left" rowspan="1" colspan="1">67.2 (76/113)<sup>a</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;6</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">105</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">55.2 (58/105)<sup>ab</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;4</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">105</td><td align="left" rowspan="1" colspan="1">53</td><td align="left" rowspan="1" colspan="1">50.4 (53/105)<sup>b</sup>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Note: The same superscript letters in the same column indicate no statistically significant differences (<italic>p</italic> &#x0003e; 0.05); different superscript letters in the same column indicate statistically significant differences (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><p>The PB1 extrusion rate of sheep oocytes was examined after 24 h of <italic>in vitro</italic> maturation. After 24 h of culture, the PB1 extrusion rate of mature sheep oocytes in the 10<sup>&#x02212;4</sup> mol/l U0126 group (28.6%) was significantly decreased compared with control (48.4%, <italic>p</italic> &#x0003c; 0.05). There was no significant differences between the 10<sup>&#x02212;6</sup> mol/l U0126 group and the control group (32.3% vs 48.4%, <italic>p &#x0003e;</italic> 0.05) (<xref rid="pone.0120418.t003" ref-type="table">Table 3</xref>). Microscopic characteristics of sheep oocyte maturation stained with aceto-orcein are illustrated in <xref rid="pone.0120418.g001" ref-type="fig">Fig. 1</xref>.</p><fig id="pone.0120418.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.g001</object-id><label>Fig 1</label><caption><title>Microscopic characteristics of sheep oocyte maturation stained with aceto-orcein (200&#x000d7; magnification).</title><p>(A) Oocyte at GV stage, arrow points to germinal vesicle; (B) oocyte at GVBD stage, arrow points to condensed chromosomes; (C) oocyte at late spindle stage, arrow points to spindle fibers; and (D) oocyte at middle MII stage, arrow points to the first polar body.</p></caption><graphic xlink:href="pone.0120418.g001"/></fig><table-wrap id="pone.0120418.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.t003</object-id><label>Table 3</label><caption><title>Statistics of the first polar body (PB1) extrusion rate of sheep oocytes in different treatment groups after 24 h of <italic>in vitro</italic> maturation.</title></caption><alternatives><graphic id="pone.0120418.t003g" xlink:href="pone.0120418.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Total number of oocytes</th><th align="left" rowspan="1" colspan="1">Number of oocytes with PB1 extrusion</th><th align="left" rowspan="1" colspan="1">PB1 extrusion rate(%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="left" rowspan="1" colspan="1">62</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">48.4(30/42)<sup>a</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;6</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1">21</td><td align="left" rowspan="1" colspan="1">32.3(21/65)<sup>ab</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;4</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">28.6(20/70)<sup>b</sup>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Note: The same superscript letters in the same column indicate no statistically significant differences (<italic>p</italic> &#x0003e; 0.05); different superscript letters in the same column indicate statistically significant differences (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec016"><title>The distribution of &#x003b1;-tubulin in different treatment groups</title><p>The distribution of &#x003b1;-tubulin in sheep oocytes at different maturity periods were examined by immunofluorescence staining (<xref rid="pone.0120418.g002" ref-type="fig">Fig. 2</xref>). As the culture time elapsed, the amount of &#x003b1;-tubulin distributed around chromosomes increased. In treatments, the occurrence of &#x003b1;-tubulin aggregation around chromosomes and the spindle formation in oocytes were later than that in control. After 18 h of <italic>in vitro</italic> maturation, 69% (48/70) of oocytes in the control group entered anaphase of meiosis, some oocytes even entered the metaphase of meiosis, i.e., the MII stage. But in the 10<sup>&#x02212;4</sup> mol/l U0126 group, approximately 50% (36/71) of oocytes remained in the metaphase of meiosis I.</p><fig id="pone.0120418.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.g002</object-id><label>Fig 2</label><caption><title>The &#x003b1;-tubulin distribution around chromosomes in sheep oocytes after different periods of <italic>in vitro</italic> maturation.</title><p>Red indicates chromosomes and green indicates &#x003b1;-tubulin. (A1-C1, 4 h) Oocytes show GVBD in the control group (group I, A1, 10&#x000d7;40) and the 10<sup>&#x02212;4</sup> mol/l U0126 group (group III, C1, 10&#x000d7;20), but remain in the germinal vesicle stage in the 10<sup>&#x02212;6</sup> mol/l U0126 group (group II, B1,10&#x000d7;40); (A2-C2, 8 h) chromosome condensation (A2, 10&#x000d7;40), beginning of chromosome condensation (B2,10&#x000d7;20), and GVBD (C2, 10&#x000d7;40); (A3-C3, 12 h) telophase of meiosis I (A3, 10&#x000d7;20; B3, 10&#x000d7;40), and chromosome condensation (C3, 10&#x000d7;40); (A4&#x02013;C4, 24 h) meiosis II (A4, B4, 10&#x000d7;40), and telophase of meiosis I (C4, 10&#x000d7;20).</p></caption><graphic xlink:href="pone.0120418.g002"/></fig></sec><sec id="sec017"><title>The distribution of &#x003b1;-tubulin in sheep oocyte nucleus after 22 h of in vitro maturation</title><p>The experimental results were interpreted in accordance with the classification of &#x003b1;-tubulin by Miyara [<xref rid="pone.0120418.ref014" ref-type="bibr">14</xref>]. <xref rid="pone.0120418.g003" ref-type="fig">Fig. 3A&#x02013;C</xref> show an abnormal distribution of &#x003b1;-tubulin, and <xref rid="pone.0120418.g003" ref-type="fig">Fig. 3D&#x02013;F</xref> show a normal distribution. Statistics of the distribution of &#x003b1;-tubulin in different groups of sheep oocytes after 22 h of <italic>in vitro</italic> maturation are shown in <xref rid="pone.0120418.t004" ref-type="table">Table 4</xref>.</p><fig id="pone.0120418.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.g003</object-id><label>Fig 3</label><caption><title>The &#x003b1;-tubulin distribution around chromosomes in sheep oocytes after 22 h of <italic>in vitro</italic> maturation.</title><p>Red indicates chromosomes and green indicates &#x003b1;-tubulin. (A, 10&#x000d7;40) Disorderly distribution of chromosomes; (B, 10&#x000d7;40) little &#x003b1;-tubulin distributed around chromosomes; (C,10&#x000d7;20) nearly no &#x003b1;-tubulin distributed around chromosomes; (D, 10&#x000d7;40) &#x003b1;-tubulin distributed on a spindle; and (E, F, 10&#x000d7;40) formation of microtubules and extrusion of polar bodies at meiosis II.</p></caption><graphic xlink:href="pone.0120418.g003"/></fig><table-wrap id="pone.0120418.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.t004</object-id><label>Table 4</label><caption><title>Statistics of the distribution of &#x003b1;-tubulin of sheep oocytes in different treatment groups after 22 h of <italic>in vitro</italic> maturation.</title></caption><alternatives><graphic id="pone.0120418.t004g" xlink:href="pone.0120418.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Total number of oocytes</th><th align="left" rowspan="1" colspan="1">Number of oocytes with normal distribution of &#x003b1;-tubulin</th><th align="left" rowspan="1" colspan="1">Normal distribution rate of &#x003b1;-tubulin (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="left" rowspan="1" colspan="1">152</td><td align="left" rowspan="1" colspan="1">103</td><td align="left" rowspan="1" colspan="1">68a</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;6</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">149</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">59<sup>ab</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;4</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">155</td><td align="left" rowspan="1" colspan="1">85</td><td align="left" rowspan="1" colspan="1">54<sup>b</sup>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>Note: The same superscript letters in the same column indicate no statistically significant differences (<italic>p</italic> &#x0003e; 0.05); different superscript letters in the same column indicate statistically significant differences (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap><p>Statistical analysis showed that the normal distribution rate of &#x003b1;-tubulin in sheep oocytes after 22 h of <italic>in vitro</italic> maturation decreased with an increasing dose of the inhibitor, with 54% in the 10<sup>&#x02212;4</sup> mol/l U0126 group, significantly lower than 68% in the control group (<italic>p</italic> &#x0003c; 0.05). This indicated that the addition of U0126 affected normal expression of &#x003b1;-tubulin and its distribution in sheep oocytes.</p></sec><sec id="sec018"><title>In vitro fertilization of sheep oocytes in different treatment groups</title><p>After <italic>in vitro</italic> fertilization, sheep oocytes in theatments had significantly lower cleavage rates than those in the control group (<italic>p</italic> &#x0003c; 0.01). The blastocyst rate of oocytes in the 10<sup>&#x02212;4</sup> mol/l U0126 group (13.0%) was significantly decreased compared with control (29.9%, <italic>p &#x0003c;</italic> 0.05), with no significant differences between the 10<sup>&#x02212;6</sup> mol/l U0126 group and the control group (24.6% vs 29.9%, <italic>p &#x0003e;</italic> 0.05) (<xref rid="pone.0120418.t005" ref-type="table">Table 5</xref>).</p><table-wrap id="pone.0120418.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0120418.t005</object-id><label>Table 5</label><caption><title>The cleavage and blastocyst rates of sheep oocytes in different treatment groups after <italic>in vitro</italic> fertilization.</title></caption><alternatives><graphic id="pone.0120418.t005g" xlink:href="pone.0120418.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Number of embryos transferred</th><th align="left" rowspan="1" colspan="1">Number of cleaved embryos</th><th align="left" rowspan="1" colspan="1">Cleavage rate (%)</th><th align="left" rowspan="1" colspan="1">Number of blastocysts</th><th align="left" rowspan="1" colspan="1">Blastocyst rate (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Control</td><td align="left" rowspan="1" colspan="1">137</td><td align="left" rowspan="1" colspan="1">99</td><td align="left" rowspan="1" colspan="1">72.3 (99/137) <sup>A</sup>
</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">29.9(41/137)<sup>a</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;6</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">118</td><td align="left" rowspan="1" colspan="1">67</td><td align="left" rowspan="1" colspan="1">56.8 (67/118) <sup>Ba</sup>
</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">24.6(29/118)<sup>a</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10<sup>&#x02212;4</sup> mol/l U0126 group</td><td align="left" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">42.6 (46/108) <sup>Bb</sup>
</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">17.6(19/108)<sup>b</sup>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Note: The same superscript letters in the same column indicate no statistically significant differences (<italic>p</italic> &#x0003e; 0.05); different superscript letters in the same column indicate statistically significant differences (<italic>p</italic> &#x0003c; 0.05).</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec019"><title>Discussion</title><p>EGF has been shown to facilitate the <italic>in vitro</italic> maturation of sheep oocytes, and enhance embryo&#x02019;s capability for further development [<xref rid="pone.0120418.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pone.0120418.ref023" ref-type="bibr">23</xref>]. However, its molecular mechanism underlying which has not been defined clearly. This study focused on investigating the effect of the EGF-mediated MAPK3/1 pathway on <italic>in vitro</italic> maturation of sheep oocytes. We used U0126, a specific inhibitor of MEK, to block the EGF-mediated MAPK3/1 pathway. The results showed that the addition of U0126 decreased the GVBD rate and the PB1 extrusion rate of sheep oocytes, and affected the normal expression and the distribution of &#x003b1;-tubulin in sheep oocytes. Further study showed that U0126 could reduce the cleavage and blastocyst rate after <italic>in vitro</italic> fertilization. Thus, these results suggest that EGF-mediated MAPK3/1 pathway is conducive to <italic>in vitro</italic> maturation of sheep oocytes.</p><p>As a specific inhibitor of MEK, U0126 has been widely used in studies of oocyte maturation with effective inhibition of MAPK3/1 activity [<xref rid="pone.0120418.ref025" ref-type="bibr">25</xref>&#x02013;<xref rid="pone.0120418.ref027" ref-type="bibr">27</xref>]. More than 80% inhibition of MEK enzymic activity could be achieved by 10<sup>&#x02212;6</sup>&#x02013;10<sup>&#x02212;5</sup> mol/l U0126 in somatic cells [<xref rid="pone.0120418.ref028" ref-type="bibr">28</xref>]. In our study, 10<sup>&#x02212;6</sup> mol/l U0126 had no effect on the nuclear maturation and blastocyst development, but 10<sup>&#x02212;4</sup> mol/l U0126 exhibited a significant effect on them. These results were consistent with previous studies that block of ERK1/2 activity by 10<sup>&#x02212;5</sup> mol/l U0126 only slightly inhibited EGF-induced meiotic resumption [<xref rid="pone.0120418.ref007" ref-type="bibr">7</xref>], and only 10<sup>&#x02212;4</sup> mol/l U0126 could completely inhibit the effect of LH-induced GVB in cultured mouse follicles [<xref rid="pone.0120418.ref029" ref-type="bibr">29</xref>].</p><p>MAPK3/1 are co-expressed in all mammalian tissues and play a pivotal role in GVBD in oocytes. While the activation time of MAPK3/1 were variable among species. In rat, mouse and goat, their activation occurred after GVBD, which meant that they just involved in regulating post-GVBD events and were not required for GVBD [<xref rid="pone.0120418.ref030" ref-type="bibr">30</xref>&#x02013;<xref rid="pone.0120418.ref032" ref-type="bibr">32</xref>]. In pig, cattle and Xenopus, MAPK3/1 were activated before GVBD or synchronously to induce GVBD [<xref rid="pone.0120418.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0120418.ref035" ref-type="bibr">35</xref>]. However, the effect of MAPK3/1 on sheep GVBD was unknown. As can be seen from our results, addition of U0126 inhibited EGF-induced GVBD. This indicates that the MAPK3/1 pathway could affect the occurrence of GVBD in sheep.</p><p>The PB1 extrusion rate as a symbol of the oocyte nuclear maturation, is very important for embryo development after <italic>in vitro</italic> fertilization. Sakaguchi reported that the supplement of EGF and insulin-like growth factor-1 (IGF-1) could significantly increase the frequency of oocytes with PB1 at 16 h of culture (<italic>p</italic> &#x0003c; 0.05) [<xref rid="pone.0120418.ref036" ref-type="bibr">36</xref>]. But the mechanism is unclear. Our results showed that the PB1 extrusion rate of mature sheep oocytes in the 10<sup>&#x02212;4</sup> mol/l U0126 group was significantly decreased compared with control (28.6% vs 48.4%, <italic>p</italic> &#x0003c; 0.05), indicating that EGF could promote the extrusion of PB1 during sheep oocyte maturation <italic>in vitro</italic> via MAPK3/1 pathway.</p><p>In oocytes, after GVBD and PB1 extrusion, chromosomes in secondary oocytes form a metaphase plate with the long axis parallel to the cell membrane surface, which indicates that the oocyte nucleus has matured. The distribution of chromosomes and the morphology of the spindle in mature oocytes impact the development of the fertilized oocyte. Disorderly spindle assembly can cause abnormal distribution of chromosomes in oocytes, thereby preventing the extrusion of the first and the second polar body. It may also lead to the formation of aneuploid zygotes [<xref rid="pone.0120418.ref037" ref-type="bibr">37</xref>]. Therefore, the assembly and normal distribution of tubulin should be one of the focuses for evaluating the quality of the mature oocyte nucleus. Our results showed that, among different treatments of sheep oocytes, there existed obvious morphological differences of the aggregation and the distribution of &#x003b1;-tubulin around chromosomes after 22 h of <italic>in vitro</italic> maturation. The rate of oocytes in the telophase of meiosis in the control group was significantly increased compared with the drug treatments. Combined comparison with the distribution of &#x003b1;-tubulin at different time showed that the above phenomenon was possibly related to the speed of &#x003b1;-tubulin aggregation around chromosomes and the formation of microtubules, thereby affecting the distribution and separation time of chromosomes. These showed that U0126 significantly inhibited the expression of &#x003b1;-tubulin and its aggregation around chromosomes. This demonstrated that the EGF-mediated MAPK3/1 pathway could promote normal distribution of chromosomes and &#x003b1;-tubulin in sheep oocytes, further improving the quality of oocytes&#x02019; nuclear maturation, which were consistent with previous observations in mouse and pig oocytes [<xref rid="pone.0120418.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0120418.ref039" ref-type="bibr">39</xref>]. Furthermore, EGF has been shown to exert positive effects on cleavage rate and blastocyst formation during <italic>in vitro</italic> maturation process of sheep oocytes [<xref rid="pone.0120418.ref021" ref-type="bibr">21</xref>&#x02013;<xref rid="pone.0120418.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0120418.ref040" ref-type="bibr">40</xref>]. Our results showed that MAPK3/1 affected the cleavage and blastocyst rates after <italic>in vitro</italic> fertilization of oocytes. All of these results demonstrate that EGF could regulate <italic>in vitro</italic> maturation of sheep oocytes via the MAPK3/1 pathway.</p><p>However, some studies suggest that MAPK3/1 are necessary but not sufficient to induce oocyte maturation. In cultured cumulus-oocyte complexes, activation of MAPK3/1 in cumulus cells with growth differentiation factor 9 (GDF9) alone is not sufficient to stimulate oocyte maturation [<xref rid="pone.0120418.ref029" ref-type="bibr">29</xref>]. Reduced but measureable levels of phosphorylated MAPK3/1 are induced by LH in <italic>Areg</italic>
<sup><italic>&#x02212;/&#x02212;</italic></sup>
<italic>Egfr</italic>
<sup><italic>wa2/wa2</italic></sup> follicles, yet oocyte meiotic resumption is impaired [<xref rid="pone.0120418.ref041" ref-type="bibr">41</xref>]. Recent studies have demonstrated that an additional pathway may involved in LH-induced oocyte maturation. It has been shown that NPPC increases cGMP levels in granulosa cells via activation of NPR2, then the cGMP diffusing into oocyte via gap junctions, where it acts to maintain meiotic arrest by inhibiting phosphodiesterase (PDE) 3A activity and cAMP hydrolysis [<xref rid="pone.0120418.ref002" ref-type="bibr">2</xref>, <xref rid="pone.0120418.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0120418.ref043" ref-type="bibr">43</xref>]. In addition, activation of LH receptors decreases both <italic>Nppc</italic> and <italic>Npr2</italic> mRNA expression [<xref rid="pone.0120418.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0120418.ref045" ref-type="bibr">45</xref>]. LH treatment also results in a reduction in NPR2 activity in mouse ovarian follicles, contributing to the decrease of cGMP leveles [<xref rid="pone.0120418.ref045" ref-type="bibr">45</xref>]. Thus, LH-induced decrease in NPPC content and NPR2 activity may reduce cGMP levels in the follicle, which enabling the oocytes to resume meiosis [<xref rid="pone.0120418.ref045" ref-type="bibr">45</xref>]. However, both MAPK3/1 pathway and NPPC/NPR2 are essential components of the LH signaling required to oocyte maturation, the correlation between them remains unclear. Further investigations into that will provide a better understanding of oocyte maturation in mammals and will be helpful for further improving the <italic>in vitro</italic> culture system of sheep oocytes.</p></sec></body><back><ack><p>We thank Di Chang and Hongwu Yang for their help with the data analysis. We also thank Ya Gao, Hongbin Liang, and Zili Lin for sampling.</p></ack><ref-list><title>References</title><ref id="pone.0120418.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Park</surname><given-names>JY</given-names></name>, <name><surname>Su</surname><given-names>YQ</given-names></name>, <name><surname>Ariga</surname><given-names>M</given-names></name>, <name><surname>Law</surname><given-names>E</given-names></name>, <name><surname>Jin</surname><given-names>SL</given-names></name>, <name><surname>Conti</surname><given-names>M</given-names></name>. <article-title>EGF-like growth factors as mediators of LH action in the ovulatory follicle</article-title>. <source>Science</source>. <year>2004</year>;<volume>303</volume>:<fpage>682</fpage>&#x02013;<lpage>684</lpage>.
<pub-id pub-id-type="pmid">14726596</pub-id></mixed-citation></ref><ref id="pone.0120418.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>M</given-names></name>, <name><surname>Xia</surname><given-names>G</given-names></name>. <article-title>Hormonal control of mammalian oocyte meiosis at diplotene stage. Cellular and molecular life sciences</article-title>: <source>CMLS</source>. <year>2012</year>;<volume>69</volume>:<fpage>1279</fpage>&#x02013;<lpage>1288</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-011-0867-3</pub-id>
<pub-id pub-id-type="pmid">22045555</pub-id></mixed-citation></ref><ref id="pone.0120418.ref003"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Su</surname><given-names>YQ</given-names></name>, <name><surname>Wigglesworth</surname><given-names>K</given-names></name>, <name><surname>Pendola</surname><given-names>FL</given-names></name>, <name><surname>O'Brien</surname><given-names>MJ</given-names></name>, <name><surname>Eppig</surname><given-names>JJ</given-names></name>. <article-title>Mitogen-activated protein kinase activity in cumulus cells is essential for gonadotropin-induced oocyte meiotic resumption and cumulus expansion in the mouse</article-title>. <source>Endocrinology</source>. <year>2002</year>;<volume>143</volume>:<fpage>2221</fpage>&#x02013;<lpage>2232</lpage>.
<pub-id pub-id-type="pmid">12021186</pub-id></mixed-citation></ref><ref id="pone.0120418.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Torcia</surname><given-names>S</given-names></name>, <name><surname>Xie</surname><given-names>F</given-names></name>, <name><surname>Lin</surname><given-names>CJ</given-names></name>, <name><surname>Cakmak</surname><given-names>H</given-names></name>, <name><surname>Franciosi</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes</article-title>. <source>Nature cell biology</source>. <year>2013</year>;<volume>15</volume>:<fpage>1415</fpage>&#x02013;<lpage>1423</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2873</pub-id>
<pub-id pub-id-type="pmid">24270888</pub-id></mixed-citation></ref><ref id="pone.0120418.ref005"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Zhang</surname><given-names>M</given-names></name>, <name><surname>Su</surname><given-names>YQ</given-names></name>, <name><surname>Sugiura</surname><given-names>K</given-names></name>, <name><surname>Xia</surname><given-names>G</given-names></name>, <name><surname>Eppig</surname><given-names>JJ</given-names></name>. <article-title>Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes</article-title>. <source>Science</source>. <year>2010</year>;<volume>330</volume>:<fpage>366</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1126/science.1193573</pub-id>
<pub-id pub-id-type="pmid">20947764</pub-id></mixed-citation></ref><ref id="pone.0120418.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Tsuji</surname><given-names>T</given-names></name>, <name><surname>Kiyosu</surname><given-names>C</given-names></name>, <name><surname>Akiyama</surname><given-names>K</given-names></name>, <name><surname>Kunieda</surname><given-names>T</given-names></name>. <article-title>CNP/NPR2 signaling maintains oocyte meiotic arrest in early antral follicles and is suppressed by EGFR-mediated signaling in preovulatory follicles</article-title>. <source>Molecular reproduction and development</source>. <year>2012</year>;<volume>79</volume>:<fpage>795</fpage>&#x02013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1002/mrd.22114</pub-id>
<pub-id pub-id-type="pmid">22987720</pub-id></mixed-citation></ref><ref id="pone.0120418.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Kong</surname><given-names>N</given-names></name>, <name><surname>Li</surname><given-names>N</given-names></name>, <name><surname>Hao</surname><given-names>X</given-names></name>, <name><surname>Wei</surname><given-names>K</given-names></name>, <name><surname>Xiang</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Epidermal growth factor receptor signaling-dependent calcium elevation in cumulus cells is required for NPR2 inhibition and meiotic resumption in mouse oocytes</article-title>. <source>Endocrinology</source>. <year>2013</year>;<volume>154</volume>:<fpage>3401</fpage>&#x02013;<lpage>3409</lpage>. <pub-id pub-id-type="doi">10.1210/en.2013-1133</pub-id>
<pub-id pub-id-type="pmid">23787120</pub-id></mixed-citation></ref><ref id="pone.0120418.ref008"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Vaccari</surname><given-names>S</given-names></name>, <name><surname>Weeks</surname><given-names>JL</given-names><suffix>2nd</suffix></name>, <name><surname>Hsieh</surname><given-names>M</given-names></name>, <name><surname>Menniti</surname><given-names>FS</given-names></name>, <name><surname>Conti</surname><given-names>M</given-names></name>. <article-title>Cyclic GMP signaling is involved in the luteinizing hormone-dependent meiotic maturation of mouse oocytes</article-title>. <source>Biology of reproduction</source>. <year>2009</year>;<volume>81</volume>:<fpage>595</fpage>&#x02013;<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod.109.077768</pub-id>
<pub-id pub-id-type="pmid">19474061</pub-id></mixed-citation></ref><ref id="pone.0120418.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Norris</surname><given-names>RP</given-names></name>, <name><surname>Freudzon</surname><given-names>M</given-names></name>, <name><surname>Nikolaev</surname><given-names>VO</given-names></name>, <name><surname>Jaffe</surname><given-names>LA</given-names></name>. <article-title>Epidermal growth factor receptor kinase activity is required for gap junction closure and for part of the decrease in ovarian follicle cGMP in response to LH</article-title>. <source>Reproduction</source>. <year>2010</year>;<volume>140</volume>:<fpage>655</fpage>&#x02013;<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1530/REP-10-0288</pub-id>
<pub-id pub-id-type="pmid">20826538</pub-id></mixed-citation></ref><ref id="pone.0120418.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Conti</surname><given-names>M</given-names></name>, <name><surname>Hsieh</surname><given-names>M</given-names></name>, <name><surname>Zamah</surname><given-names>AM</given-names></name>, <name><surname>Oh</surname><given-names>JS</given-names></name>. <article-title>Novel signaling mechanisms in the ovary during oocyte maturation and ovulation</article-title>. <source>Molecular and cellular endocrinology</source>. <year>2012</year>;<volume>356</volume>:<fpage>65</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2011.11.002</pub-id>
<pub-id pub-id-type="pmid">22101318</pub-id></mixed-citation></ref><ref id="pone.0120418.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Fan</surname><given-names>HY</given-names></name>, <name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Shimada</surname><given-names>M</given-names></name>, <name><surname>Sterneck</surname><given-names>E</given-names></name>, <name><surname>Johnson</surname><given-names>PF</given-names></name>, <name><surname>Hedrick</surname><given-names>SM</given-names></name>, <etal>et al</etal>
<article-title>MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility</article-title>. <source>Science</source>. <year>2009</year>;<volume>324</volume>:<fpage>938</fpage>&#x02013;<lpage>941</lpage>. <pub-id pub-id-type="doi">10.1126/science.1171396</pub-id>
<pub-id pub-id-type="pmid">19443782</pub-id></mixed-citation></ref><ref id="pone.0120418.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Fan</surname><given-names>HY</given-names></name>, <name><surname>Tong</surname><given-names>C</given-names></name>, <name><surname>Lian</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>SW</given-names></name>, <name><surname>Gao</surname><given-names>WX</given-names></name>, <name><surname>Cheng</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Characterization of ribosomal S6 protein kinase p90rsk during meiotic maturation and fertilization in pig oocytes: mitogen-activated protein kinase-associated activation and localization</article-title>. <source>Biology of reproduction</source>. <year>2003</year>;<volume>68</volume>:<fpage>968</fpage>&#x02013;<lpage>977</lpage>.
<pub-id pub-id-type="pmid">12604650</pub-id></mixed-citation></ref><ref id="pone.0120418.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Choi</surname><given-names>T</given-names></name>, <name><surname>Fukasawa</surname><given-names>K</given-names></name>, <name><surname>Zhou</surname><given-names>R</given-names></name>, <name><surname>Tessarollo</surname><given-names>L</given-names></name>, <name><surname>Borror</surname><given-names>K</given-names></name>, <name><surname>Resau</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>The Mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>1996</year>;<volume>93</volume>:<fpage>7032</fpage>&#x02013;<lpage>7035</lpage>.
<pub-id pub-id-type="pmid">8692939</pub-id></mixed-citation></ref><ref id="pone.0120418.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Gordo</surname><given-names>AC</given-names></name>, <name><surname>He</surname><given-names>CL</given-names></name>, <name><surname>Smith</surname><given-names>S</given-names></name>, <name><surname>Fissore</surname><given-names>RA</given-names></name>. <article-title>Mitogen activated protein kinase plays a significant role in metaphase II arrest, spindle morphology, and maintenance of maturation promoting factor activity in bovine oocytes</article-title>. <source>Molecular reproduction and development</source>. <year>2001</year>;<volume>59</volume>:<fpage>106</fpage>&#x02013;<lpage>114</lpage>.
<pub-id pub-id-type="pmid">11335952</pub-id></mixed-citation></ref><ref id="pone.0120418.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Martino</surname><given-names>A</given-names></name>, <name><surname>Palomo</surname><given-names>MJ</given-names></name>, <name><surname>Mogas</surname><given-names>T</given-names></name>, <name><surname>Paramio</surname><given-names>MT</given-names></name>. <article-title>Influence of the collection technique of prepubertal goat oocytes on in vitro maturation and fertilization</article-title>. <source>Theriogenology</source>. <year>1994</year>;<volume>42</volume>:<fpage>859</fpage>&#x02013;<lpage>873</lpage>.
<pub-id pub-id-type="pmid">16727591</pub-id></mixed-citation></ref><ref id="pone.0120418.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Mermillod</surname><given-names>POB</given-names></name>, <name><surname>Cogni&#x000e9;</surname><given-names>Y</given-names></name>. <article-title>Aspects of follicular and oocyte maturation that affect the developmental potential of embryos</article-title>. <source>J Reprod Fertil Suppl</source>. <year>1999</year>;<volume>54</volume>:<fpage>449</fpage>&#x02013;<lpage>460</lpage>.
<pub-id pub-id-type="pmid">10692875</pub-id></mixed-citation></ref><ref id="pone.0120418.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Trounson</surname><given-names>A</given-names></name>, <name><surname>Anderiesz</surname><given-names>C</given-names></name>, <name><surname>Jones</surname><given-names>G</given-names></name>. <article-title>Maturation of human oocytes in vitro and their developmental competence</article-title>. <source>Reproduction</source>. <year>2001</year>;<volume>121</volume>:<fpage>51</fpage>&#x02013;<lpage>75</lpage>.
<pub-id pub-id-type="pmid">11226029</pub-id></mixed-citation></ref><ref id="pone.0120418.ref018"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Morgan</surname><given-names>PM</given-names></name>, <name><surname>Warikoo</surname><given-names>PK</given-names></name>, <name><surname>Bavister</surname><given-names>BD</given-names></name>. <article-title>In vitro maturation of ovarian oocytes from unstimulated rhesus monkeys: assessment of cytoplasmic maturity by embryonic development after in vitro fertilization</article-title>. <source>Biology of reproduction</source>. <year>1991</year>;<volume>45</volume>:<fpage>89</fpage>&#x02013;<lpage>93</lpage>.
<pub-id pub-id-type="pmid">1878439</pub-id></mixed-citation></ref><ref id="pone.0120418.ref019"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Barnes</surname><given-names>FL</given-names></name>, <name><surname>Crombie</surname><given-names>A</given-names></name>, <name><surname>Gardner</surname><given-names>DK</given-names></name>, <name><surname>Kausche</surname><given-names>A</given-names></name>, <name><surname>Lacham-Kaplan</surname><given-names>O</given-names></name>, <name><surname>Suikkari</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Blastocyst development and birth after in-vitro maturation of human primary oocytes, intracytoplasmic sperm injection and assisted hatching</article-title>. <source>Hum Reprod</source>. <year>1995</year>;<volume>10</volume>:<fpage>3243</fpage>&#x02013;<lpage>3247</lpage>.
<pub-id pub-id-type="pmid">8822452</pub-id></mixed-citation></ref><ref id="pone.0120418.ref020"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Kim</surname><given-names>DH</given-names></name>, <name><surname>Ko</surname><given-names>DS</given-names></name>, <name><surname>Lee</surname><given-names>HC</given-names></name>, <name><surname>Lee</surname><given-names>HJ</given-names></name>, <name><surname>Park</surname><given-names>WI</given-names></name>, <name><surname>Kim</surname><given-names>SS</given-names></name>, <etal>et al</etal>
<article-title>Comparison of maturation, fertilization, development, and gene expression of mouse oocytes grown in vitro and in vivo</article-title>. <source>Journal of assisted reproduction and genetics</source>. <year>2004</year>;<volume>21</volume>:<fpage>233</fpage>&#x02013;<lpage>240</lpage>.
<pub-id pub-id-type="pmid">15526980</pub-id></mixed-citation></ref><ref id="pone.0120418.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Guler</surname><given-names>A</given-names></name>, <name><surname>Poulin</surname><given-names>N</given-names></name>, <name><surname>Mermillod</surname><given-names>P</given-names></name>, <name><surname>Terqui</surname><given-names>M</given-names></name>, <name><surname>Cognie</surname><given-names>Y</given-names></name>. <article-title>Effect of growth factors, EGF and IGF-I, and estradiol on in vitro maturation of sheep oocytes</article-title>. <source>Theriogenology</source>. <year>2000</year>;<volume>54</volume>:<fpage>209</fpage>&#x02013;<lpage>218</lpage>.
<pub-id pub-id-type="pmid">11003302</pub-id></mixed-citation></ref><ref id="pone.0120418.ref022"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Shabankareh</surname><given-names>HK</given-names></name>, <name><surname>Zandi</surname><given-names>M</given-names></name>. <article-title>Developmental potential of sheep oocytes cultured in different maturation media: effects of epidermal growth factor, insulin-like growth factor I, and cysteamine</article-title>. <source>Fertility and sterility</source>. <year>2010</year>;<volume>94</volume>:<fpage>335</fpage>&#x02013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.01.160</pub-id>
<pub-id pub-id-type="pmid">19324348</pub-id></mixed-citation></ref><ref id="pone.0120418.ref023"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Grazul-Bilska</surname><given-names>AT</given-names></name>, <name><surname>Choi</surname><given-names>JT</given-names></name>, <name><surname>Bilski</surname><given-names>JJ</given-names></name>, <name><surname>Weigl</surname><given-names>RM</given-names></name>, <name><surname>Kirsch</surname><given-names>JD</given-names></name>, <name><surname>Kraft</surname><given-names>KC</given-names></name>, <etal>et al</etal>
<article-title>Effects of epidermal growth factor on early embryonic development after in vitro fertilization of oocytes collected from ewes treated with follicle stimulating hormone</article-title>. <source>Theriogenology</source>. <year>2003</year>;<volume>59</volume>:<fpage>1449</fpage>&#x02013;<lpage>1457</lpage>.
<pub-id pub-id-type="pmid">12527091</pub-id></mixed-citation></ref><ref id="pone.0120418.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Zhao</surname><given-names>HC</given-names></name>, <name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Yu</surname><given-names>Y</given-names></name>, <name><surname>Qiao</surname><given-names>J</given-names></name>. <article-title>Chromosomal aberrations in in-vitro matured oocytes influence implantation and ongoing pregnancy rates in a mouse model undergoing intracytoplasmic sperm injection</article-title>. <source>PloS one</source>. <year>2014</year>;<volume>9</volume>:<fpage>e103347</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0103347</pub-id>
<pub-id pub-id-type="pmid">25058692</pub-id></mixed-citation></ref><ref id="pone.0120418.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Kondoh</surname><given-names>E</given-names></name>, <name><surname>Tachibana</surname><given-names>K</given-names></name>, <name><surname>Deguchi</surname><given-names>R</given-names></name>. <article-title>Intracellular Ca2+ increase induces post-fertilization events via MAP kinase dephosphorylation in eggs of the hydrozoan jellyfish Cladonema pacificum</article-title>. <source>Developmental biology</source>. <year>2006</year>;<volume>293</volume>:<fpage>228</fpage>&#x02013;<lpage>241</lpage>.
<pub-id pub-id-type="pmid">16530749</pub-id></mixed-citation></ref><ref id="pone.0120418.ref026"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Philipova</surname><given-names>R</given-names></name>, <name><surname>Kisielewska</surname><given-names>J</given-names></name>, <name><surname>Lu</surname><given-names>P</given-names></name>, <name><surname>Larman</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>JY</given-names></name>, <name><surname>Whitaker</surname><given-names>M</given-names></name>. <article-title>ERK1 activation is required for S-phase onset and cell cycle progression after fertilization in sea urchin embryos</article-title>. <source>Development</source>. <year>2005</year>;<volume>132</volume>:<fpage>579</fpage>&#x02013;<lpage>589</lpage>.
<pub-id pub-id-type="pmid">15634691</pub-id></mixed-citation></ref><ref id="pone.0120418.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Phillips</surname><given-names>KP</given-names></name>, <name><surname>Petrunewich</surname><given-names>MA</given-names></name>, <name><surname>Collins</surname><given-names>JL</given-names></name>, <name><surname>Booth</surname><given-names>RA</given-names></name>, <name><surname>Liu</surname><given-names>XJ</given-names></name>, <name><surname>Baltz</surname><given-names>JM</given-names></name>. <article-title>Inhibition of MEK or cdc2 kinase parthenogenetically activates mouse eggs and yields the same phenotypes as Mos(-/-) parthenogenotes</article-title>. <source>Developmental biology</source>. <year>2002</year>;<volume>247</volume>:<fpage>210</fpage>&#x02013;<lpage>223</lpage>.
<pub-id pub-id-type="pmid">12074563</pub-id></mixed-citation></ref><ref id="pone.0120418.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Favata</surname><given-names>MF</given-names></name>, <name><surname>Horiuchi</surname><given-names>KY</given-names></name>, <name><surname>Manos</surname><given-names>EJ</given-names></name>, <name><surname>Daulerio</surname><given-names>AJ</given-names></name>, <name><surname>Stradley</surname><given-names>DA</given-names></name>, <name><surname>Feeser</surname><given-names>WS</given-names></name>, <etal>et al</etal>
<article-title>Identification of a novel inhibitor of mitogen-activated protein kinase kinase</article-title>. <source>The Journal of biological chemistry</source>. <year>1998</year>;<volume>273</volume>:<fpage>18623</fpage>&#x02013;<lpage>18632</lpage>.
<pub-id pub-id-type="pmid">9660836</pub-id></mixed-citation></ref><ref id="pone.0120418.ref029"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Su</surname><given-names>YQ</given-names></name>, <name><surname>Denegre</surname><given-names>JM</given-names></name>, <name><surname>Wigglesworth</surname><given-names>K</given-names></name>, <name><surname>Pendola</surname><given-names>FL</given-names></name>, <name><surname>O'Brien</surname><given-names>MJ</given-names></name>, <name><surname>Eppig</surname><given-names>JJ</given-names></name>. <article-title>Oocyte-dependent activation of mitogen-activated protein kinase (ERK1/2) in cumulus cells is required for the maturation of the mouse oocyte-cumulus cell complex</article-title>. <source>Developmental biology</source>. <year>2003</year>;<volume>263</volume>:<fpage>126</fpage>&#x02013;<lpage>138</lpage>.
<pub-id pub-id-type="pmid">14568551</pub-id></mixed-citation></ref><ref id="pone.0120418.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Dedieu</surname><given-names>T</given-names></name>, <name><surname>Gall</surname><given-names>L</given-names></name>, <name><surname>Crozet</surname><given-names>N</given-names></name>, <name><surname>Sevellec</surname><given-names>C</given-names></name>, <name><surname>Ruffini</surname><given-names>S</given-names></name>. <article-title>Mitogen-activated protein kinase activity during goat oocyte maturation and the acquisition of meiotic competence</article-title>. <source>Molecular reproduction and development</source>. <year>1996</year>;<volume>45</volume>:<fpage>351</fpage>&#x02013;<lpage>358</lpage>.
<pub-id pub-id-type="pmid">8916046</pub-id></mixed-citation></ref><ref id="pone.0120418.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Smith</surname><given-names>GD</given-names></name>, <name><surname>Chen</surname><given-names>DY</given-names></name>, <name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Han</surname><given-names>ZM</given-names></name>, <name><surname>Schatten</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Phosphorylation of mitogen-activated protein kinase is regulated by protein kinase C, cyclic 3',5'-adenosine monophosphate, and protein phosphatase modulators during meiosis resumption in rat oocytes</article-title>. <source>Biology of reproduction</source>. <year>2001</year>;<volume>64</volume>:<fpage>1444</fpage>&#x02013;<lpage>1450</lpage>.
<pub-id pub-id-type="pmid">11319150</pub-id></mixed-citation></ref><ref id="pone.0120418.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>SE</given-names></name>, <name><surname>Kim</surname><given-names>JH</given-names></name>, <name><surname>Kim</surname><given-names>NH</given-names></name>. <article-title>Inactivation of MAPK affects centrosome assembly, but not actin filament assembly, in mouse oocytes maturing in vitro</article-title>. <source>Molecular reproduction and development</source>. <year>2007</year>;<volume>74</volume>:<fpage>904</fpage>&#x02013;<lpage>911</lpage>.
<pub-id pub-id-type="pmid">17219430</pub-id></mixed-citation></ref><ref id="pone.0120418.ref033"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Ferrell</surname><given-names>JE</given-names><suffix>Jr</suffix></name>, <name><surname>Wu</surname><given-names>M</given-names></name>, <name><surname>Gerhart</surname><given-names>JC</given-names></name>, <name><surname>Martin</surname><given-names>GS</given-names></name>. <article-title>Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs</article-title>. <source>Molecular and cellular biology</source>. <year>1991</year>;<volume>11</volume>:<fpage>1965</fpage>&#x02013;<lpage>1971</lpage>.
<pub-id pub-id-type="pmid">2005892</pub-id></mixed-citation></ref><ref id="pone.0120418.ref034"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Fissore</surname><given-names>RA</given-names></name>, <name><surname>He</surname><given-names>CL</given-names></name>, <name><surname>Vande</surname><given-names>Woude GF</given-names></name>. <article-title>Potential role of mitogen-activated protein kinase during meiosis resumption in bovine oocytes</article-title>. <source>Biology of reproduction</source>. <year>1996</year>;<volume>55</volume>:<fpage>1261</fpage>&#x02013;<lpage>1270</lpage>.
<pub-id pub-id-type="pmid">8949882</pub-id></mixed-citation></ref><ref id="pone.0120418.ref035"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Inoue</surname><given-names>M</given-names></name>, <name><surname>Naito</surname><given-names>K</given-names></name>, <name><surname>Aoki</surname><given-names>F</given-names></name>, <name><surname>Toyoda</surname><given-names>Y</given-names></name>, <name><surname>Sato</surname><given-names>E</given-names></name>. <article-title>Activation of mitogen-activated protein kinase during meiotic maturation in porcine oocytes</article-title>. <source>Zygote</source>. <year>1995</year>;<volume>3</volume>:<fpage>265</fpage>&#x02013;<lpage>271</lpage>.
<pub-id pub-id-type="pmid">8903796</pub-id></mixed-citation></ref><ref id="pone.0120418.ref036"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Sakaguchi</surname><given-names>M</given-names></name>, <name><surname>Dominko</surname><given-names>T</given-names></name>, <name><surname>Leibfried-Rutledge</surname><given-names>ML</given-names></name>, <name><surname>Nagai</surname><given-names>T</given-names></name>, <name><surname>First</surname><given-names>NL</given-names></name>. <article-title>A combination of EGF and IGF-I accelerates the progression of meiosis in bovine follicular oocytes in vitro and fetal calf serum neutralizes the acceleration effect</article-title>. <source>Theriogenology</source>. <year>2000</year>;<volume>54</volume>:<fpage>1327</fpage>&#x02013;<lpage>1342</lpage>.
<pub-id pub-id-type="pmid">11192191</pub-id></mixed-citation></ref><ref id="pone.0120418.ref037"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Miyara</surname><given-names>F</given-names></name>, <name><surname>Aubriot</surname><given-names>FX</given-names></name>, <name><surname>Glissant</surname><given-names>A</given-names></name>, <name><surname>Nathan</surname><given-names>C</given-names></name>, <name><surname>Douard</surname><given-names>S</given-names></name>, <name><surname>Stanovici</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Multiparameter analysis of human oocytes at metaphase II stage after IVF failure in non-male infertility</article-title>. <source>Hum Reprod</source>. <year>2003</year>;<volume>18</volume>:<fpage>1494</fpage>&#x02013;<lpage>1503</lpage>.
<pub-id pub-id-type="pmid">12832378</pub-id></mixed-citation></ref><ref id="pone.0120418.ref038"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Sun</surname><given-names>QY</given-names></name>, <name><surname>Lai</surname><given-names>L</given-names></name>, <name><surname>Park</surname><given-names>KW</given-names></name>, <name><surname>Kuhholzer</surname><given-names>B</given-names></name>, <name><surname>Prather</surname><given-names>RS</given-names></name>, <name><surname>Schatten</surname><given-names>H</given-names></name>. <article-title>Dynamic events are differently mediated by microfilaments, microtubules, and mitogen-activated protein kinase during porcine oocyte maturation and fertilization in vitro</article-title>. <source>Biology of reproduction</source>. <year>2001</year>;<volume>64</volume>:<fpage>879</fpage>&#x02013;<lpage>889</lpage>.
<pub-id pub-id-type="pmid">11207204</pub-id></mixed-citation></ref><ref id="pone.0120418.ref039"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Verlhac</surname><given-names>MH</given-names></name>, <name><surname>de Pennart</surname><given-names>H</given-names></name>, <name><surname>Maro</surname><given-names>B</given-names></name>, <name><surname>Cobb</surname><given-names>MH</given-names></name>, <name><surname>Clarke</surname><given-names>HJ</given-names></name>. <article-title>MAP kinase becomes stably activated at metaphase and is associated with microtubule-organizing centers during meiotic maturation of mouse oocytes</article-title>. <source>Developmental biology</source>. <year>1993</year>;<volume>158</volume>:<fpage>330</fpage>&#x02013;<lpage>340</lpage>.
<pub-id pub-id-type="pmid">8344454</pub-id></mixed-citation></ref><ref id="pone.0120418.ref040"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Kelly</surname><given-names>JM</given-names></name>, <name><surname>Kleemann</surname><given-names>DO</given-names></name>, <name><surname>Maxwell</surname><given-names>WM</given-names></name>, <name><surname>Walker</surname><given-names>SK</given-names></name>. <article-title>Effects of insulin-like growth factor-I, epidermal growth factor and cysteamine on the in vitro maturation and development of oocytes collected from 6- to 8-week-old Merino lambs</article-title>. <source>Reproduction, fertility, and development</source>. <year>2008</year>;<volume>20</volume>:<fpage>570</fpage>&#x02013;<lpage>578</lpage>.
<pub-id pub-id-type="pmid">18577354</pub-id></mixed-citation></ref><ref id="pone.0120418.ref041"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Hsieh</surname><given-names>M</given-names></name>, <name><surname>Lee</surname><given-names>D</given-names></name>, <name><surname>Panigone</surname><given-names>S</given-names></name>, <name><surname>Horner</surname><given-names>K</given-names></name>, <name><surname>Chen</surname><given-names>R</given-names></name>, <name><surname>Theologis</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation</article-title>. <source>Molecular and cellular biology</source>. <year>2007</year>;<volume>27</volume>:<fpage>1914</fpage>&#x02013;<lpage>1924</lpage>.
<pub-id pub-id-type="pmid">17194751</pub-id></mixed-citation></ref><ref id="pone.0120418.ref042"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Richards</surname><given-names>JS</given-names></name>. <article-title>New signaling pathways for hormones and cyclic adenosine 3',5'-monophosphate action in endocrine cells</article-title>. <source>Mol Endocrinol</source>. <year>2001</year>;<volume>15</volume>:<fpage>209</fpage>&#x02013;<lpage>218</lpage>.
<pub-id pub-id-type="pmid">11158328</pub-id></mixed-citation></ref><ref id="pone.0120418.ref043"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Norris</surname><given-names>RP</given-names></name>, <name><surname>Ratzan</surname><given-names>WJ</given-names></name>, <name><surname>Freudzon</surname><given-names>M</given-names></name>, <name><surname>Mehlmann</surname><given-names>LM</given-names></name>, <name><surname>Krall</surname><given-names>J</given-names></name>, <name><surname>Movsesian</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte</article-title>. <source>Development</source>. <year>2009</year>;<volume>136</volume>:<fpage>1869</fpage>&#x02013;<lpage>1878</lpage>. <pub-id pub-id-type="doi">10.1242/dev.035238</pub-id>
<pub-id pub-id-type="pmid">19429786</pub-id></mixed-citation></ref><ref id="pone.0120418.ref044"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Kawamura</surname><given-names>K</given-names></name>, <name><surname>Cheng</surname><given-names>Y</given-names></name>, <name><surname>Kawamura</surname><given-names>N</given-names></name>, <name><surname>Takae</surname><given-names>S</given-names></name>, <name><surname>Okada</surname><given-names>A</given-names></name>, <name><surname>Kawagoe</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes</article-title>. <source>Hum Reprod</source>. <year>2011</year>;<volume>26</volume>:<fpage>3094</fpage>&#x02013;<lpage>3101</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/der282</pub-id>
<pub-id pub-id-type="pmid">21865234</pub-id></mixed-citation></ref><ref id="pone.0120418.ref045"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Robinson</surname><given-names>JW</given-names></name>, <name><surname>Zhang</surname><given-names>M</given-names></name>, <name><surname>Shuhaibar</surname><given-names>LC</given-names></name>, <name><surname>Norris</surname><given-names>RP</given-names></name>, <name><surname>Geerts</surname><given-names>A</given-names></name>, <name><surname>Wunder</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes</article-title>. <source>Developmental biology</source>. <year>2012</year>;<volume>366</volume>:<fpage>308</fpage>&#x02013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2012.04.019</pub-id>
<pub-id pub-id-type="pmid">22546688</pub-id></mixed-citation></ref></ref-list></back></article>